Impact of JN.1 Variant on Heart Health
Author Information
Author(s): Chhotaray Sangeeta, Sahoo Pralaya Kumar, Mekap Suman Kumar, Jal Soumya, Pattnaik Gurudutta
Primary Institution: Centurion University of Technology and Management, Bhubaneswar, India
Hypothesis
What is the prevalence of the JN.1 infection in the development and progression of cardiac-related clinical disorders?
Conclusion
The JN.1 variant of COVID-19 may significantly impact cardiovascular health and increase the risk of heart disease.
Supporting Evidence
- 20.6% of patients hospitalized with COVID-19 had new and ongoing high blood pressure during a 6-month follow-up.
- Individuals with chronic conditions are at a higher risk of infection from COVID-19.
- The JN.1 variant has shown a consistent upward trend in global detection.
Takeaway
A new version of the COVID-19 virus called JN.1 might make heart problems worse for some people.
Methodology
A comprehensive literature analysis was conducted using databases from the WHO and the American Heart Association, covering articles from March 2020 to August 2022.
Limitations
Confounding factors like lifestyle and genetic predisposition may not have been sufficiently controlled, and results may not be applicable to other populations.
Participant Demographics
The study involved individuals diagnosed with COVID-19, with a focus on those with a history of hypertension.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website